J. Jonkman

发表

Comparison of Galenic Formulations of Orlistat (Tetrahydrolipstatin)

D. Hartmann, C. Güzelhan, P. Peeters, 1993 .

Electrophysiologic and Pharmacokinetic Profile of the New Antiarrhythmic Drug TYB‐3823 in Humans

K. Lie, H. Crijns, C. Mensink, 1993, Journal of cardiovascular pharmacology.

THE CHRONOPHARMACOLOGY AND CHRONOTHERAPY OF ASTHMA

P. Barnes, M. Smolensky, P. Scott, 1986 .

Inhibitory Effect of Telmisartan on the Blood Pressure Response to Angiotensin II Challenge

J. V. van Lier, J. Stangier, J. Jonkman, 2001, Journal of cardiovascular pharmacology.

Absorption, metabolism and excretion of a single oral dose of 14C-repaglinide during repaglinide multiple dosing

J. V. van Lier, J. Jonkman, J. Jonkman, 1999, European Journal of Clinical Pharmacology.

Absorption, Metabolism, and Excretion of Intravenously and Orally Administered [14C]Telmisartan in Healthy Volunteers

J. Stangier, D. Türck, P. Peeters, 2000, Journal of clinical pharmacology.

The Effect of Telmisartan on the Steady‐State Pharmacokinetics of Digoxin in Healthy Male Volunteers

J. Stangier, J. Jonkman, B. Oosterhuis, 2000, Journal of clinical pharmacology.

An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19

J. Jonkman, B. Oosterhuis, R. D. de Zeeuw, 2001, European Journal of Clinical Pharmacology.

Pharmacokinetics and pharmacodynamics of the endothelin‐receptor antagonist bosentan in healthy human subjects

G. Hopfgartner, C. Weber, P. Peeters, 1996, Clinical pharmacology and therapeutics.

Rosiglitazone: No Effect on Erythropoiesis or Premature Red Cell Destruction

P. Dogterom, J. Jonkman, S. Vallance, 1999 .

Troglitazone has no effect on red cell mass or other erythropoietic parameters

L. Squassante, P. Dogterom, J. Jonkman, 1999, European Journal of Clinical Pharmacology.

Steady‐State Pharmacodynamics and Pharmacokinetics of Warfarin in the Presence and Absence of Telmisartan in Healthy Male Volunteers

J. Stangier, J. Jonkman, B. Oosterhuis, 2000, Journal of clinical pharmacology.

Pharmacokinetic drug interaction studies with candesartan cilexetil.

R. Lins, J. V. van Lier, J. Jonkman, 1997, Journal of human hypertension.

The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers.

D. Smith, E. Seaber, J. V. van Lier, 1998, British journal of clinical pharmacology.

A Comparison of the Pharmacokinetics and Tolerability of Riluzole after Repeat Dose Administration in Healthy Elderly and Young Volunteers

G. Montay, J. Gautier, P. Peeters, 1999, Journal of clinical pharmacology.

Single‐dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1–84)] in healthy postmenopausal volunteers

J. Jonkman, F. Sollie, E. Groen, 1997, Clinical pharmacology and therapeutics.

Selective quantitative determination of methylxanthines and methyluric acids in urine

S. Riegelman, K. Muir, J. Jonkman, 1982 .

Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography

S. Riegelman, K. Muir, J. Jonkman, 1980 .

No Pharmacokinetic or Pharmacodynamic Interaction Between Theophylline and the Leukotriene Biosynthesis Inhibitor BAY x 1005

O. Leeuwenkamp, H. Moesker, J. Jonkman, 1996, Journal of clinical pharmacology.

Percutaneous absorption of triamcinolone acetonide from creams with and without Azone® in humans in vivo

R. A. Zeeuw, J. Jonkman, B. Drenth, 1990 .

Percutaneous Absorption and Elimination of the Penetration Enhancer Azone in Humans

J. Wiechers, J. Jonkman, B. Drenth, 1987, Pharmaceutical Research.

Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen

A. Frydman, J. Jonkman, B. Oosterhuis, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics of mirtazapine in combination with amitriptyline

J. Jonkman, C. Sennef, L. Mink, 1998, European Neuropsychopharmacology.

Ion pair absorption of ionized drugs —fact or fiction ?

C. Hunt, J. Jonkman, J. H. G. Jonkman, 1983, Pharmaceutisch Weekblad.

Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation

J. Dingemanse, A. Guenzi, J. Jonkman, 1992, Clinical and experimental dermatology.

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

A. Peer, Z. Żylicz, J. Heykants, 1993, Clinical pharmacology and therapeutics.

Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers

A. Smout, P. Peeters, J. Jonkman, 1995, Alimentary Pharmacology and Therapeutics.

Exploring the boundaries of bioanalytical quantitative LC–MS–MS

Maarten Honing, M. Honing, Fija M. Lagerwerf, 2000 .

ANALYSIS OF QUATERNARY AMMONIUM-COMPOUNDS AND BASIC DRUGS BASED ON ION-PAIR ADSORPTION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

R. A. Zeeuw, J. Jonkman, J. Greving, 1979 .

AS A PROBE FOR THE CYP 2 C 19 ACTIVITY : A CRITICAL EVALUATION OF ITS APPLICABILITY IN EPIDEMIOLOGY AND CLINICAL PHARMACOLOGY

R. A. Zeeuw, B. Wilffert, D. Touw, 2018 .

2.1 MEPHENYTOIN AS A PROBE FOR THE CYP2C19 ACTIVITY: A CRITICAL EVALUATION OF ITS APPLICABILITY IN EPIDEMIOLOGY AND CLINICAL PHARMACOLOGY

R. A. Zeeuw, B. Wilffert, D. Touw, 2001 .

Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects.

J. Jonkman, W. Roth, E. Bauer, 1993, Journal of pharmaceutical sciences.

Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single doses

G. Bianchetti, P. Morselli, J. Thénot, 2004, European Journal of Clinical Pharmacology.

PART III APPLICATION IN EPIDEMIOLOGY 3 . 1 CYP 2 D 6 AND CYP 2 C 19 ACTIVITY IN A LARGE POPULATION OF DUTCH HEALTHY VOLUNTEERS : INDICATIONS FOR ORAL CONTRACEPTIVE-RELATED GENDER DIFFERENCES

R. A. Zeeuw, B. Wilffert, J. Wieling, 2018 .

Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study

R. A. Zeeuw, A. Boer, L. Leij, 2003, European Journal of Clinical Pharmacology.

Percutaneous absorption, metabolism, and elimination of the penetration enhancer Azone in humans after prolonged application under occlusion

R. A. Zeeuw, J. Wiechers, J. Jonkman, 1988 .

Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection

J. Jonkman, A. Verhagen, A. Dogterom, 2004, European Journal of Clinical Pharmacology.

A comparative study of the steady-state pharmacokinetics of immediate-release and controlled-release diltiazem tablets

O. Leeuwenkamp, C. Mensink, J. Jonkman, 2004, European Journal of Clinical Pharmacology.

Determination of carboxylic acids in the picomole range after derivatization with pentafluorobenzyl bromide and electron capture gas chromatography

R. A. Zeeuw, J. Jonkman, J. Greving, 1978 .

The theophylline-erythromycin interaction.

L. Hendeles, J. Jonkman, 1983, Chest.

Plasticizers as contaminants in high-purity solvents: a potential source of interference in biological analysis.

J. Jonkman, R. Dezeeuw, F. J. van Mansvelt, 1975, Analytical biochemistry.

The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine

A. Richens, J. Hulsman, M. Eve, 1991, Clinical pharmacology and therapeutics.

Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Bosentan, an Endothelin Receptor Antagonist, in Healthy Male Volunteers

G. Hopfgartner, C. Weber, H. Eggers, 1999, Journal of clinical pharmacology.

Pharmacokinetics, a modern view. Edited by L. Z. Benet, G. Levy, and B. L. Ferraiolo. Plenum Press, New York, 1984. xvi + 531 pp. 17 × 26 cm. ISBN 0-306-4180-. $65.00

J. Jonkman, 1986 .

Determination of low concentrations of the quaternary ammonium compound thiazinamium methylsulphate in plasma and urine

R. A. Zeeuw, J. Jonkman, J. Wijsbeek, 1975 .

Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan®) in man

R. A. Zeeuw, J. Jonkman, A. Soeterboek, 1982, Pharmaceutisch Weekblad.

Novel Chromatographic methods for monitoring quaternary ammonium compounds in biological fluids

R. A. Zeeuw, J. Jonkman, H. G. Westenberg, 1980, Pharmaceutisch Weekblad.

Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.

J. Kneer, H. Groen, J. Dingemanse, 1995, Journal of clinical psychopharmacology.

Multiple dose pharmacokinetics of tiludronate in healthy volunteers

J. Necciari, J. Dingemanse, P. Peeters, 1996, European Journal of Clinical Pharmacology.

Randomised crossover comparison of adrenal suppressive effects of dermal creams containing glucocorticosteroids

J. Jonkman, H. Visscher, J. Ebels, 2004, European Journal of Clinical Pharmacology.

No Influence of Single Intravenous Doses of Omeprazole on Theophylline Elimination Kinetics

T. Andersson, J. Jonkman, T. Andersson, 1992, Journal of clinical pharmacology.

Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin

J. Jonkman, J. Jansen, S. Snel, 1998, European Journal of Clinical Pharmacology.

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

R. A. Zeeuw, B. Wilffert, J. Wieling, 1999, European Journal of Clinical Pharmacology.

Variations in the bioavailability of thiazinamium methylsulfate

J. Jonkman, J. Wijsbeek, R. D. de Zeeuw, 1977, Clinical pharmacology and therapeutics.

Absorption and Mass Balance of Mgk R11 and Mgk R11 Formulated with Deet, Mgk 264, and Mgk 326 Following an 8 Hour Dermal Exposure in Human Volunteers

K. L. Gabriel, J. Jonkman, S. Selim, 1995 .

DERMAL ABSORPTION AND MASS BALANCE OF MGK 326 AND REFORMULATED MGK 326 IN HUMAN VOLUNTEERS

K. L. Gabriel, J. Jonkman, S. Selim, 1994 .

Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma.

J. Wieling, J Hempenius, J Wieling, 1996, Journal of chromatography. A.

The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaints.

K. Wesnes, O. Petrini, K A Wesnes, 1997, Psychopharmacology bulletin.

Phenotypic Differences in Dextromethorphan Metabolism

B. Cabana, J. Jonkman, L. Leeson, 2004, Pharmaceutical Research.

Dose-dependent uricosuric effect of ambroxol

J. Jonkman, B. Oosterhuis, P. Cornelissen, 2004, European Journal of Clinical Pharmacology.

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.

T. Andersson, J. Jonkman, J. Jonkman, 1991, British journal of clinical pharmacology.

Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening.

J. Wieling, J. Jonkman, J. Jonkman, 2000, Therapeutic drug monitoring.

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

R. A. Zeeuw, J. Jonkman, J. Jonkman, 2001, European Journal of Clinical Pharmacology.

Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration

R. A. Zeeuw, J. Jonkman, J. Wijsbeek, 1974 .